New treatment for drug-resistant breast cancer found

Researchers investigating the way in which HER2-positive breast cancer becomes resistant to treatment have made a surprising discovery concerning how this resistance develops. However, they may have also discovered a way to prevent this resistance from manifesting entirely. The study, published in Cell Reports reveals a new combination therapy involving...

Read More

Antimalarial tea — from herbal remedy to licensed phytomedicine

ANTIMALARIAL TEA — FROM HERBAL REMEDY TO LICENSED PHYTOMEDICINE Malaria is a critical health problem in West Africa, where traditional medicine is commonly used alongside modern healthcare practices. An herbal remedy derived from the roots of a weed, which was traditionally used to alleviate malarial symptoms, was combined with leaves and aerial portions from two other...

Read More

New blood tests will speed up diagnosis for the most common GI disorder

New blood tests will speed up diagnosis for the most common GI disorder Millions of people afflicted by irritable bowel syndrome can now be diagnosed quickly and accurately with two simple blood tests developed by a Cedars-Sinai gastroenterologist. The tests, created by Mark Pimentel, MD, director of the GI Motility Program and Laboratory, confirm when a patient...

Read More

new small molecule drug may treate Drug-resistant TB

Drug-resistant TB may be treatable with new small molecule drug Written by Catharine Paddock PhD In a new study, scientists report how a new small molecule drug appears able to kill drug-resistant tuberculosis without toxic side effects. Tuberculosis known as TB – is an infection caused by the bacterium Mycobacterium tuberculosis. TB can spread to any organ...

Read More

New method detects more breast cancer in screening

NEW METHOD DETECTS MORE BREAST CANCER IN SCREENING 8 May 2015 Tomosynthesis detects 40% more breast cancers than traditional mammography does, according to a major screening study from Lund University, Sweden. This is the first large-scale study to compare the screening method with regular mammograms. The 3D X-ray technique is also more comfortable for women,...

Read More

New PARP Inhibitor Combo Shows Early Promise for Cancer Patients With and Without BRCA Mutations

A combination of two molecularly targeted drugs, olaparib and the investigational agent AZD5363, was safe and yielded responses in patients with a variety of cancer types, including breast, ovarian, and prostate cancers, regardless of BRCA1/2 mutation status, according to data from the ComPAKT phase I clinical trial presented here at the AACR Annual Meeting...

Read More